SCYNEXIS INC (SCYX) has 59 open-market insider trades by 18 insiders since 2014. The most active filer is Marco Taglietti, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Biopharma Partners Ii Lp Alta | 10% | — | 1 | $9.0M | 2014-05-07 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 1 | $7.3M | 2021-01-22 |
| Marco Taglietti | CEO | — | 25 | $2.3M | 2022-04-26 |
| Jean-Yves Nothias | Dir | — | 1 | $500K | 2014-05-07 |
| Biotechnology Fund Fcpr | 10% | — | 1 | $500K | 2014-05-07 |
| David Angulo Gonzalez | — | — | 12 | $324K | 2026-01-29 |
| Ventech Capital II | 10% | — | 1 | $280K | 2014-05-07 |
| Guy Macdonald | Dir | — | 2 | $146K | 2026-06-26 |
| Patrick Machado | Dir | — | 1 | $118K | 2016-09-15 |
| Genavent F.c.p.r. | 10% | — | 1 | $100K | 2014-05-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Angulo Gonzalez | CEO | Buy | $27K | 2024-09-12 |
| Scott Sukenick | General Counsel | Buy | $11K | 2022-04-26 |
| Marco Taglietti | CEO | Buy | $225K | 2022-04-26 |
| Perceptive LIFE Sciences Master FUND Ltd. | 10% Owner | Sell | $7.3M | 2021-01-20 |
| Steven C. Gilman | Director | Buy | $25K | 2020-12-21 |
| David Angulo Gonzalez | Chief Medical Officer | Buy | $10K |
Companies that share insiders with SCYX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-12-21 |
| Brian Philippe Tinmouth | Director | Buy | $50K | 2020-12-21 |
| Armando Anido | Director | Buy | $31K | 2020-12-21 |
| Marco Taglietti | CEO | Buy | $250K | 2020-12-21 |
| Eric Francois | CFO | Buy | $4K | 2020-12-21 |
| Marco Taglietti | CEO | Buy | $300K | 2019-12-12 |
| Marco Taglietti | CEO | Buy | $11K | 2019-08-20 |
| Marco Taglietti | CEO | Buy | $10K | 2019-08-15 |
| Marco Taglietti | CEO | Buy | $41K | 2019-04-17 |
| Marco Taglietti | CEO | Buy | $17K | 2019-01-10 |